Chloroquine for the 2019 novel coronavirus SARS-CoV-2.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 32070753)

Published in Int J Antimicrob Agents on February 15, 2020

Authors

Philippe Colson1, Jean-Marc Rolain1, Didier Raoult2

Author Affiliations

1: Aix-Marseille Université, Institut de Recherche pour le Développement (IRD), Assistance Publique-Hôpitaux de Marseille (AP-HM), MEPHI, 27 boulevard Jean Moulin, 13005 Marseille, France; IHU Méditerranée Infection, 19-21 boulevard Jean Moulin, 13005 Marseille, France.
2: Aix-Marseille Université, Institut de Recherche pour le Développement (IRD), Assistance Publique-Hôpitaux de Marseille (AP-HM), MEPHI, 27 boulevard Jean Moulin, 13005 Marseille, France; IHU Méditerranée Infection, 19-21 boulevard Jean Moulin, 13005 Marseille, France. Electronic address: didier.raoult@gmail.com.

Associated clinical trials:

Describing Chinese Herbal Medicine Telehealth Care for Symptoms Related to Infectious Diseases Such as COVID-19 | NCT04380870